1Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United State,analysis of incidence, outcome, and associated cost of care. Crit Care M ed, 2001,29: 1303.
2Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ES-ICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med, 2003,31(4):1250.
3Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet, 1998,352(9125):391.
4Knochol JP. The pathphysiology and clinical characteristics of severe hypophoshacemia. Arch Inther Med, 1977,352:391.
6Luzzani A, Polati E, Dorizzi R,et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis[J]. Crit Care Med, 2003,31(6):1737-1741.
7Gattas DJ, Cook DJ. Procalcitonin as a diagnostic test for sepsis: health technology assessment in the ICU[J]. J Crit Care, 2003,18(1):52-58.
8Weisinger JR, Bellorin-Font E. Magnesium and phosphorus[J]. Lancet,1998,352(9125):391-396.
9Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/KSICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med, 2003,31(4):1250-1256.
10Giovannini I, Chiarla C, Nuzzo G. Pathophysiologic and clinical correlates of hypophosphatemia and the relationship with sepsis and outcome in postoperative patients after hepatectomy[J]. Shock, 2002,18(2):111-115.
